Ciprofloxacin Patent Expiration
Ciprofloxacin is Used for treating ear infections and inflammation in both pediatric and adult patients. It was first introduced by Bayer Healthcare Pharmaceuticals Inc
Ciprofloxacin Patents
Given below is the list of patents protecting Ciprofloxacin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cipro | US5695784 | Flavor-masked pharmaceutical compositions |
Dec 09, 2014
(Expired) | Bayer Hlthcare |
| Cipro |
US5695784 (Pediatric) | Flavor-masked pharmaceutical compositions |
Jun 09, 2015
(Expired) | Bayer Hlthcare |
| Cipro | US6136347 | Flavor-masked pharmaceutical compositions |
Jan 06, 2013
(Expired) | Bayer Hlthcare |
| Cipro |
US6136347 (Pediatric) | Flavor-masked pharmaceutical compositions |
Jul 06, 2013
(Expired) | Bayer Hlthcare |
| Otiprio | US11040004 | Otic gel formulations for treating otitis externa | Nov 12, 2037 | Alk Abello |
| Otiprio | US11246863 | Ciprofloxacin otic composition and kits and method for using same | Nov 27, 2038 | Alk Abello |
| Otiprio | US11369566 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | Apr 21, 2029 | Alk Abello |
| Otiprio | US8318817 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | Apr 27, 2030 | Alk Abello |
| Otiprio | US9205048 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | Apr 21, 2029 | Alk Abello |
| Otiprio | US9220796 | Sterilization of ciprofloxacin composition | Jul 01, 2035 | Alk Abello |
| Otiprio | US9233068 | Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders | Dec 11, 2029 | Alk Abello |
| Otiprio | US9603796 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | Apr 21, 2029 | Alk Abello |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Ciprofloxacin Generics
Several generic applications have been filed for Ciprofloxacin. The first generic version for Ciprofloxacin was by Hospira Inc and was approved on Aug 28, 2006. And the latest generic version is by Chartwell Life Molecules Llc and was approved on Mar 5, 2014.
Given below is the list of companies who have filed for Ciprofloxacin generic.
1. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Ciprofloxacin. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG/20ML (10MG/ML) | injectable | Discontinued | INJECTION | N/A | Aug 28, 2006 |
| 400MG/40ML (10MG/ML) | injectable | Discontinued | INJECTION | N/A | Aug 28, 2006 |
2. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Ciprofloxacin. All of these versions come by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG/100ML | injectable | Discontinued | INJECTION | N/A | Mar 18, 2008 |
| 400MG/200ML | injectable | Discontinued | INJECTION | N/A | Mar 18, 2008 |
3. HOSPIRA
Hospira Inc has filed for 4 different strengths of generic version for Ciprofloxacin. Out of these 200mg/100ml version comes by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, 400mg/200ml version comes by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Hospira.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 400MG/40ML (10MG/ML) | injectable | Discontinued | INJECTION | N/A | Aug 28, 2006 |
| 200MG/20ML (10MG/ML) | injectable | Discontinued | INJECTION | N/A | Aug 28, 2006 |
| 200MG/100ML
(reference standard) | injectable | Prescription | INJECTION | AP | Mar 18, 2008 |
| 400MG/200ML
(reference standard) | injectable | Prescription | INJECTION | AP | Mar 18, 2008 |
4. INFORLIFE
Inforlife Sa has filed for 2 different strengths of generic version for Ciprofloxacin. All of these versions come by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Inforlife.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG/100ML | injectable | Prescription | INJECTION | AP | Mar 18, 2008 |
| 400MG/200ML | injectable | Prescription | INJECTION | AP | Mar 18, 2008 |
5. CHARTWELL
Chartwell Life Molecules Llc has filed for 2 different strengths of generic version for Ciprofloxacin. Given below are the details of the strengths of this generic introduced by Chartwell.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/5ML | for suspension | Prescription | ORAL | AB | Mar 5, 2014 |
| 250MG/5ML | for suspension | Prescription | ORAL | AB | Mar 5, 2014 |
6. BAXTER HLTHCARE CORP
Baxter Healthcare Corp has filed for 4 different strengths of generic version for Ciprofloxacin. Out of these 200mg/100ml version comes by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, 400mg/200ml version comes by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Baxter Hlthcare Corp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG/100ML | injectable | Prescription | INJECTION | AP | Mar 18, 2008 |
| 400MG/200ML | injectable | Prescription | INJECTION | AP | Mar 18, 2008 |
| 400MG/40ML (10MG/ML)
(reference standard) | injectable | Prescription | INJECTION | AP | Apr 29, 2008 |
| 200MG/20ML (10MG/ML)
(reference standard) | injectable | Prescription | INJECTION | AP | Apr 29, 2008 |
7. HIKMA FARMACEUTICA
Hikma Farmaceutica (portugal) Sa has filed for 4 different strengths of generic version for Ciprofloxacin. Out of these 200mg/100ml version comes by the name CIPROFLOXACIN IN DEXTROSE 5%, 400mg/200ml version comes by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Hikma Farmaceutica.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG/100ML | injectable | Discontinued | INJECTION | N/A | Apr 21, 2008 |
| 400MG/200ML | injectable | Prescription | INJECTION | AP | Nov 18, 2009 |
| 400MG/40ML (10MG/ML) | injectable | Prescription | INJECTION | AP | Dec 22, 2009 |
| 200MG/20ML (10MG/ML) | injectable | Prescription | INJECTION | AP | Dec 22, 2009 |
8. BEDFORD
Bedford Laboratories Div Ben Venue Laboratories Inc has filed for 2 different strengths of generic version for Ciprofloxacin. All of these versions come by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Bedford.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG/100ML | injectable | Discontinued | INJECTION | N/A | Mar 18, 2008 |
| 400MG/200ML | injectable | Discontinued | INJECTION | N/A | Mar 18, 2008 |
9. BEDFORD LABS
Bedford Laboratories has filed for 3 different strengths of generic version for Ciprofloxacin. Given below are the details of the strengths of this generic introduced by Bedford Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG/20ML (10MG/ML) | injectable | Discontinued | INJECTION | N/A | Aug 28, 2006 |
| 400MG/40ML (10MG/ML) | injectable | Discontinued | INJECTION | N/A | Aug 28, 2006 |
| 1200MG/120ML (10MG/ML) | injectable | Discontinued | INJECTION | N/A | Aug 28, 2006 |
10. BAXTER HLTHCARE
Baxter Healthcare Corp has filed for 2 different strengths of generic version for Ciprofloxacin. All of these versions come by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Baxter Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG/100ML | injectable | Discontinued | INJECTION | N/A | Mar 18, 2008 |
| 400MG/200ML | injectable | Discontinued | INJECTION | N/A | Mar 18, 2008 |
11. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 2 different strengths of generic version for Ciprofloxacin. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG/20ML (10MG/ML) | injectable | Discontinued | INJECTION | N/A | Aug 28, 2006 |
| 400MG/40ML (10MG/ML) | injectable | Discontinued | INJECTION | N/A | Aug 28, 2006 |